共 50 条
- [33] Cognitive Impairment in Non-critical, Mild-to-Moderate COVID-19 Survivors [J]. FRONTIERS IN PSYCHOLOGY, 2022, 13
- [40] Bamlanivimab use in mild-to-moderate COVID-19 disease: A matched cohort design [J]. PHARMACOTHERAPY, 2021, 41 (09): : 743 - 747